Stocks

Inside P&C’s news team runs you through the key highlights of the week.

Sources said the private equity house is working with Bank of America and has approached institutional capital including PE firms and sovereign wealth funds.

Differences in business mix and definitions yield differing trajectories for brokers, but in the absence of a recession, we may see continued margin improvement.

The Bermuda-based specialist said the capital injection will boost its talent acquisition and product development plans.

CinFin lead the outperformers, while Aon and The Hartford's shares dropped sharply.

Inside P&C’s news team runs you through the key highlights of the week.

With the macro environment drying up capital streams M&A has slowed, but IPOs are reflective of pricing opportunities.

Personal lines underperform predictions, while brokers and InsurTechs are a positive surprise (for now).

After pricing below the expected range at its IPO, the Fidelis stock price slipped on the first day of trading - here's how other (re)insurance IPOs have gone since 2000.

Inside P&C’s morning summary of the key stories to get you up to speed fast.

Fidelis shares closed down from the $14 per share price set for the IPO, or a 0.8x multiple of its $17.19 book value per share at end of Q1 2023.

Bruce Lucas added that the company is no longer pursuing a Series B round.